View Author
patient transplantation study sclerosis dialysis encapsulating kidney transplantation kidney eps patients tamoxifen factor diagnosis treatment perit mario peritoniti nephrol transplant 25-03-11 4.indd incidence risk factors ultrafiltration failure development failure ultrafiltration duration post-transplantation eps group period chapter therapy survival mortality result analysis number marker sclerosing peritonitis fibrosis pd patients month sclerosing obstruction pd duration icodextrin effect registry dialysis patients control pd treatment effluent mesothelial transport post-transplantation cause sclerosing encapsulating peritonitis membrane report disease eps diagnosis dutch university fluid peritoneum korte table netherland death model center suppl stage mesothelial cells solution hospital multicenter growth population association
5 Most Recent Publications
|
Encapsulating peritoneal sclerosis: The state of affairs
(Article)
Korte, M.R. Sampimon, D.E. Betjes, M.G.H. Krediet, R.T. |
2011-09-01
|
|
Encapsulating Peritoneal Sclerosis in the Netherlands: A study on incidence, risk factors and clinical consequences
(Doctoral Thesis)
Korte, M.R. |
2011-05-27
|
|
Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation
(Article)
Korte, M.R. Lingsma, H.F. Habib S. Weimar, W. Betjes, M.G.H. |
2011-03-01
|
|
Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: Results of the Dutch Multicentre EPS Study
(Article)
Korte, M.R. Fieren, M.W.J.A. Sampimon, D.E. Roozenbeek, B. Weimar, W. Betjes, M.G.H. |
2011-02-01
|
|
Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation [10]
(Article)
Korte, M.R. Yo, M. Betjes, M.G.H. Fieren, M.W.J.A. Saase, J.C.L.M. van Boer, W.H. Weimar, W. Zietse, R. |
2007-08-01
|